Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Crossover Study Assessing the Pharmacokinetics of EFB0027 Versus ETB0015 and ETB0014 in Healthy Subjects

NCT02291510 is registered in ClinicalTrials.gov with Elcelyx Therapeutics, Inc. as lead sponsor.

NCT NCT02291510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02291510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Crossover Study Assessing the Pharmacokinetics of EFB0027 Versus ETB0015 and ETB0014 in Healthy Subjects
Lead sponsor
Elcelyx Therapeutics, Inc.
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2012
Completion date
December 31, 2012
Enrollment
20 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy subjects